CVE-2017-17677 json
BMC Remedy 9.1SP3 is affected by authenticated code execution.
published 2021-05-19 5 y ago modified 2026-07-09 4 mo ago also EUVD-2017-8834
- cvss
- 8.8
- version 3.1, NVD
- cisa kev
- Not listed
- not in CISA's catalog
- epss
- 1.1%
- EPSS 1.1% chance of exploitation in 30 days, percentile 64%
- public exploits
- 0
- none known
Summary
BMC Remedy 9.1SP3 is affected by authenticated code execution. Authenticated users that have the right to create reports can use BIRT templates to run code.
Exploit prediction
1.06% chance of exploitation in the next 30 days, higher than 64% of all scored CVEs (FIRST EPSS, 2026-11-09).
CVSS scores
| assigned by | version | score | vector |
|---|---|---|---|
| NVD | 3.1 | 8.8 | CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H |
| NVD | 2.0 | 6.5 | AV:N/AC:L/Au:S/C:P/I:P/A:P |
Classification
- Weakness
-
- CWE-732 Incorrect Permission Assignment for Critical Resource
References
-
docs.bmc.com
/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.html
release-notes, vendor-advisory
-
seclists.org
/fulldisclosure/2017/Oct/52
mailing-list, third-party-advisory
Sources
- CVE List CVE-2017-17677
- NVD CVE-2017-17677
Fencer Intel keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.